Mylan Cytarabine Recall: Particulate Matter Hazard
Mylan recalls specific lots of Cytarabine Injection due to particulate matter. Check lot #7801050 and expiration date 05/2015 for affected vials.
Stop using this now
Presence of Particulate Matter
Contact the company
What happened, in plain English
Mylan Institutional LLC is recalling Cytarabine Injection 100 mg/5 mL single-dose vials because of the presence of particulate matter. The affected product was distributed by Pfizer Labs and includes lot #7801050 with an expiration date of 05/2015. This recall covers a total of 8,340 vials distributed nationwide. Read more at govinfonow.com/recall/44734-mylan-institutional-llc-recalls-cytarabine-injection-100-mg-5-ml.
Source Summary by GovInfoNow · govinfonow.com/recall/44734-mylan-institutional-llc-recalls-cytarabine-injection-100-mg-5-ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-1329-2015
Cite this page
“Mylan Cytarabine Recall: Particulate Matter Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44734-mylan-institutional-llc-recalls-cytarabine-injection-100-mg-5-ml. Based on FDA recall #D-1329-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1329-2015%22&limit=1).
Why it’s dangerous
The presence of particulate matter in an injectable drug can pose serious health risks if introduced into the body during administration. Foreign particles in a sterile injection can cause embolisms, infections, or other severe complications.
Who’s affected
Healthcare providers and patients who received Cytarabine Injection from Pfizer Labs in the past. Specifically, those with vials from lot #7801050 expiring in May 2015 are at risk.
How to tell if you have this one
Look for Cytarabine Injection 100 mg/5 mL (20 mg/mL) in 5 mL single-dose vials. Check the carton for NDC 0069-0152-02 and the individual vial or carton for lot number 7801050 and expiration date 05/2015.
- Brand
Mylan- Category
Drug
What to do — step by step
Stop using the product
Do not administer any vials matching the recalled lot number and expiration date due to the particulate matter hazard.
Contact your supplier
Reach out to Pfizer Labs or your pharmacy/distributor for instructions on returning or disposing of the affected vials.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Who distributed the recalled Cytarabine Injection?
The product was distributed by Pfizer Labs, Division of Pfizer Inc., located in New York, NY.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1329-2015 (April 23, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1329-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.